Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.

MLA

Cusi, Kenneth, et al. “Limited Value of Plasma Cytokeratin-18 as a Biomarker for NASH and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.” Journal of Hepatology, vol. 60, no. 1, Jan. 2014, pp. 167–74. EBSCOhost, https://doi.org/10.1016/j.jhep.2013.07.042.

APA

Cusi, K., Chang, Z., Harrison, S., Lomonaco, R., Bril, F., Orsak, B., Ortiz-Lopez, C., Hecht, J., Feldstein, A. E., Webb, A., Louden, C., Goros, M., & Tio, F. (2014). Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. Journal of Hepatology, 60(1), 167–174. https://doi.org/10.1016/j.jhep.2013.07.042

Chicago

Cusi, Kenneth, Zhi Chang, Steve Harrison, Romina Lomonaco, Fernando Bril, Beverly Orsak, Carolina Ortiz-Lopez, et al. 2014. “Limited Value of Plasma Cytokeratin-18 as a Biomarker for NASH and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.” Journal of Hepatology 60 (1): 167–74. doi:10.1016/j.jhep.2013.07.042.